Ramona Sequeira is President of Takeda Pharmaceuticals U.S.A., Inc., leading the U.S. Business Unit for Takeda and President of Global Portfolio Commercialization while serving as a member of Takeda’s global Executive Team. She joined Takeda in 2015.
Prior to joining Takeda, Ms. Sequeira held a number of roles with increasing responsibly at Eli Lilly, including Vice President of Sales and Operations and Vice President of the Neuroscience Business Unit. She is a member of the PhRMA Board of Directors and was recently appointed Treasurer of the Board. Before that, Ms. Sequeira served as Chair of PhRMA’s State Committee. She also sits on the Board of the Plasma Protein Therapeutics Association (PPTA) in Annapolis, Maryland.
Ms. Sequeira holds a Master’s in Business Administration from McMaster University in Canada and a B.S. in Molecular Genetics and Molecular Biology from the University of Toronto.
Ms. Sequeira lives in Boston with her husband Doug and has two children.